We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+1.01%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+765.1%
AUM
$93.9B
AUM Growth
+$6.32B
(+7.2%)
Cap. Flow
+$695M
Cap. Flow
% of AUM
0.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
2,650
New
346
Increased
928
Reduced
896
Closed
297
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$347M |
| 2 |
Cummins
CMI
|
+$334M |
| 3 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$312M |
| 4 |
AbbVie
ABBV
|
+$285M |
| 5 |
Eaton
ETN
|
+$271M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$385M |
| 2 |
DuPont de Nemours
DD
|
+$376M |
| 3 |
GSK
GSK
|
+$357M |
| 4 |
Norfolk Southern
NSC
|
+$288M |
| 5 |
Freeport-McMoran
FCX
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.03% |
| 2 | Technology | 12.99% |
| 3 | Healthcare | 11.81% |
| 4 | Consumer Discretionary | 7.48% |
| 5 | Industrials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Smith & Nephew
SNN
$12.6B
| $4.54M | ﹤0.01% |
133,660
-2,355
| -2% | -$81.8K |
|
|
MJN
1302
PUT
DELISTED
Mead Johnson Nutrition Company
MJN
| $4.54M | ﹤0.01% |
+50,300
| New | +$4.85M |
|
1303
NeoGenomics
NEO
$2.13B
| $4.47M | ﹤0.01% |
827,188
+1,671
| +0.2% | +$8.62K |
|
1304
Moody's
MCO
$82.7B
| $4.45M | ﹤0.01% |
41,208
+17,567
| +74% | +$1.89M |
|
|
BLUE
1305
DELISTED
bluebird bio
BLUE
| $4.4M | ﹤0.01% |
2,017
-6,279
| -76% | -$12.8M |
|
1306
Petrobras
PBR
$116B
| $4.39M | ﹤0.01% |
485,335
+160,308
| +49% | +$1.43M |
|
|
LM
1307
DELISTED
Legg Mason, Inc.
LM
| $4.39M | ﹤0.01% |
85,128
+2,823
| +3% | +$152K |
|
1308
ASE Group
ASX
$82.2B
| $4.38M | ﹤0.01% |
662,557
+204,130
| +45% | +$1.42M |
|
1309
Old Dominion Freight Line
ODFL
$44.9B
| $4.37M | ﹤0.01% |
190,389
-20,013
| -10% | -$476K |
|
1310
CALL
PepsiCo
PEP
$190B
| $4.36M | ﹤0.01% |
46,700
-1,200
| -3% | -$115K |
|
1311
CALL
Honeywell
HON
$78B
| $4.35M | ﹤0.01% |
47,521
-3,672
| -7% | -$342K |
|
|
FNHC
1312
DELISTED
FedNat Holding Company Common Stock
FNHC
| $4.35M | ﹤0.01% |
179,845
-11,186
| -6% | -$304K |
|
1313
CALL
SLB Ltd
SLB
$75B
| $4.34M | ﹤0.01% |
50,400
+8,700
| +21% | +$785K |
|
1314
CALL
Boeing
BA
$185B
| $4.34M | ﹤0.01% |
31,300
+800
| +3% | +$117K |
|
|
PDLI
1315
DELISTED
PDL BioPharma, Inc.
PDLI
| $4.32M | ﹤0.01% |
672,312
-881,338
| -57% | -$5.9M |
|
1316
Wynn Resorts
WYNN
$10.6B
| $4.32M | ﹤0.01% |
43,807
+699
| +2% | +$78.9K |
|
|
SYNT
1317
DELISTED
Syntel Inc
SYNT
| $4.32M | ﹤0.01% |
90,955
+484
| +0.5% | +$23.1K |
|
1318
CALL
US Bancorp Series B Preferred Stock
USB.PRH
$746M
| $4.32M | ﹤0.01% |
99,500
+24,300
| +32% | +$538K |
|
1319
PUT
Lumen
LUMN
$6.44B
| $4.29M | ﹤0.01% |
146,200
+88,100
| +152% | +$3M |
|
1320
CALL
RTX Corp
RTX
$301B
| $4.29M | ﹤0.01% |
61,494
-5,244
| -8% | -$385K |
|
1321
Novavax
NVAX
$1.31B
| $4.26M | ﹤0.01% |
19,146
-428
| -2% | -$75.2K |
|
|
ZEUS
1322
DELISTED
Olympic Steel
ZEUS
| $4.26M | ﹤0.01% |
+244,312
| New | +$4.02M |
|
1323
Covenant Logistics
CVLG
$872M
| $4.23M | ﹤0.01% |
337,612
-3,334
| -1% | -$50.9K |
|
|
HNT
1324
DELISTED
HEALTH NET INC
HNT
| $4.23M | ﹤0.01% |
65,958
+5,928
| +10% | +$354K |
|
1325
Dominion Energy
D
$59.3B
| $4.22M | ﹤0.01% |
63,108
+6,737
| +12% | +$474K |
|
Similar funds
Allianz Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Allianz Asset Management held 2,650 positions worth $93.9B, up 7.2% from $87.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Allianz Asset Management's Q2 2015 filing shows 346 new, 928 increased, 896 reduced and 297 closed positions. Its largest new stake was UBS Group: 16,594,232 shares worth $348M. The largest sale was Baxter International, an estimated $385M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
- Allianz Asset Management's largest Q2 2015 buy was UBS Group: 16,594,232 shares worth $348M.
- Allianz Asset Management added most to Cummins in Q2 2015, an estimated $334M increase.
- Allianz Asset Management's biggest Q2 2015 reduction was Baxter International, cutting an estimated $385M.
- Allianz Asset Management fully exited GSK in Q2 2015, selling an estimated $357M.
- Allianz Asset Management's ten largest holdings make up 12% of its $93.9B portfolio in Q2 2015.
- Allianz Asset Management opened 346 new positions and closed 297 in Q2 2015.
- Allianz Asset Management's portfolio value rose 7.2% quarter-over-quarter to $93.9B.
Based on Allianz Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.